Mifamurtide
| CAS No. | 83461-56-7 | Cat. No. | BCP07203 |
| Name | Mifamurtide | ||
| Synonyms | CGP 19835A Lipid;CGP-19835; MTP-PE; MTP-cephalin; CGP19835; L-MTP-PE; MLV19835; | ||
| Formula | C59H109N6O19P | M. Wt | 1237.5 |
| Description | Mifamurtide(CGP19835; MTP-PE) is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities.. Muramyl tripeptide phosphatidylethanolamine (MTP-PE), a derivative of the mycobacterial cell wall component MDP, activates both monocytes and macrophages. Activated macrophages secrete cytokines and induce the recruitment and activation of other immune cells, which may result in indirect tumoricidal effects. Liposomal encapsulation of MTP-PE prolongs its half-life and enhances tissue targeting. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | TRP Channel | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.